STUDY OF MICE IN WHICH THE TGF BETA 1 GENE HAS BEEN DISRUPTED

对 TGF Beta 1 基因被破坏的小鼠的研究

基本信息

项目摘要

Transforming growth factor-beta (TGF-beta) has previously been implicated in embryonic development and in regulating both cell proliferation and expression of target genes. Of the three TGF-beta isoforms, type 1 TGF- beta is both the most abundant in most tissues and the most acutely regulated in injury and repair and in the pathogenesis of various diseas- es. Although they lack any obvious developmental defects, mice in which the TGF-beta1 gene has been knocked out by targeted disruption die at about 3 weeks of age of multifocal inflammatory disease. We have investigated the possible initiating event in this inflammatory syndrome and found that, prior to detection of any tissue infiltrates, expression of both class I and II major histocompatibility antigens is high in these mice, while generally undetectable in comparable tissues in normal littermates, suggesting that TGF-beta may be a natural repressor of MHC antigen expression. Moreover, we have found that the surprisingly normal development of these mice results from transfer of TGF-beta1 protein from the heterozygous mothers, both transplacentally and in the milk. By dosing with an immunosuppressant, dexamethasone, to extend the life of a female homozygous for the mutant allele, we have achieved a term delivery and been able to demonstrate that TGF-beta1 (-/-) pups born to a TGF-beta1 (-/-) mother have severe developmental defects, especially in cardiogenesis. Normal cardiogenesis is supported either by maternal transfer of TGF-beta1 from heterozygous mothers to TGF-beta1 (-/-) pups or by endogenous synthesis of TGF-beta1 in heterozygous pups born to null mothers. This demonstrates a critical role of TGF-beta1 in cardiogenesis; the role of maternal transfer of TGF-beta1 in normal physiology is not known at present.
转化生长因子-β(TGF-β)以前曾被牵连 在胚胎发育和调节细胞增殖和 目的基因的表达。 在三种TGF-β同种型中,1型TGF-β是TGF- β在大多数组织中含量最丰富, 在损伤和修复以及各种疾病的发病机制中受到调节- es. 尽管它们没有任何明显的发育缺陷, TGF-β 1基因已被靶向破坏所敲除, 约3周龄的多灶性炎性疾病。 我们有 研究了这种炎症综合征可能的起始事件 发现在检测到任何组织浸润之前, I类和II类主要组织相容性抗原在这些 小鼠,虽然在正常小鼠的可比组织中通常检测不到, 这表明TGF-β可能是MHC的天然阻遏物, 抗原表达 此外,我们还发现, 这些小鼠的发育是由于TGF-β 1蛋白从 杂合子母亲,无论是经胎盘还是在乳汁中。 通过 给药免疫抑制剂地塞米松,以延长寿命 一个突变等位基因的纯合子女性,我们已经实现了一个术语, 分娩,并能够证明TGF-β 1(-/-)幼崽出生, TGF-β 1(-/-)母亲有严重的发育缺陷, 在心脏发生中。 正常的心脏发生是由母体 TGF-β 1从杂合子母体转移到TGF-β 1(-/-)幼崽 或通过内源性合成TGF-β 1的杂合子幼崽出生的零 妈妈们 这表明TGF-β 1在 心脏发生;母亲转移TGF-β 1在正常 生理学目前还不清楚。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A B ROBERTS其他文献

A B ROBERTS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A B ROBERTS', 18)}}的其他基金

STUDY OF MICE IN WHICH THE TGF BETA GENE HAS BEEN DISRUPTED
对 TGF Beta 基因被破坏的小鼠的研究
  • 批准号:
    2463689
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF TYPE BETA TRANSFORMING GROWTH FACTOR
β型转化生长因子的作用机制
  • 批准号:
    4692310
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BIOLOGY AND RECEPTOR SIGNALLING OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和受体信号转导
  • 批准号:
    5201457
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NOVEL CHEMOPREVENTIVE AGENTS IN EXPERIMENTAL MAMMARY CARCINOGENESIS
乳腺癌实验中的新型化学预防剂
  • 批准号:
    6100875
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
  • 批准号:
    3853409
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
  • 批准号:
    3916749
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
  • 批准号:
    3838326
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STRUCTURE/FUNCTION AND SIGNAL TRANSDUCTION PATHWAYS OF TGF BETA
TGF Beta 的结构/功能和信号转导途径
  • 批准号:
    6160869
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NOVEL CHEMOPREVENTIVE AGENTS IN EXPERIMENTAL MAMMARY CARCINOGENESIS
乳腺癌实验中的新型化学预防剂
  • 批准号:
    6160975
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
  • 批准号:
    3752614
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
  • 批准号:
    22KJ2450
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
  • 批准号:
    23H03151
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    23K08067
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
  • 批准号:
    22K19629
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
  • 批准号:
    22K09763
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
  • 批准号:
    20K17570
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
  • 批准号:
    20K16311
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    20K08953
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
  • 批准号:
    20H03771
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了